These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6398307)

  • 21. Tobacco-specific nitrosamines--metabolism and biological monitoring of exposure to tobacco products.
    Richter E; Schäffler G; Malone A; Schulze J
    Clin Investig; 1992; 70(3-4):290-4. PubMed ID: 1521043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 32P-postlabelling analysis of DNA-adducts formed by 4-(N-carbethoxy-N-nitrosamino)-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)- butanal.
    Schmeiser HH; Castonguay A; Wiessler M
    IARC Sci Publ; 1993; (124):207-10. PubMed ID: 8225486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA.
    Hecht SS; Villalta PW; Sturla SJ; Cheng G; Yu N; Upadhyaya P; Wang M
    Chem Res Toxicol; 2004 May; 17(5):588-97. PubMed ID: 15144215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogenic tobacco-specific nitrosamines in Indian tobacco products.
    Nair J; Pakhale SS; Bhide SV
    Food Chem Toxicol; 1989 Nov; 27(11):751-3. PubMed ID: 2613121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological evidence for the role of nitroso compounds in human cancer.
    Preston-Martin S; Correa P
    Cancer Surv; 1989; 8(2):459-73. PubMed ID: 2696590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De minimus non curat lex--virtual thresholds for cancer initiation by tobacco specific nitrosamines--prospects for harm reduction by smokeless tobacco.
    Nilsson R
    Int J Occup Med Environ Health; 2006; 19(1):6-35. PubMed ID: 16881596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic activation and detoxification of tobacco-specific nitrosamines--a model for cancer prevention strategies.
    Hecht SS
    Drug Metab Rev; 1994; 26(1-2):373-90. PubMed ID: 8082576
    [No Abstract]   [Full Text] [Related]  

  • 28. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines.
    Falter B; Kutzer C; Richter E
    Clin Investig; 1994 May; 72(5):364-71. PubMed ID: 8086771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The occurrence of tobacco-specific nitrosamines in oral tobacco products and their potential formation under simulated gastric conditions.
    Tricker AR; Haubner R; Spiegelhalder B; Preussmann R
    Food Chem Toxicol; 1988 Oct; 26(10):861-5. PubMed ID: 3220329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.
    Hoffmann D; Hecht SS
    Cancer Res; 1985 Mar; 45(3):935-44. PubMed ID: 3882226
    [No Abstract]   [Full Text] [Related]  

  • 31. The molecular basis for induction of human cancers by tobacco specific nitrosamines.
    Nilsson R
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):268-80. PubMed ID: 21382430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobacco-specific nitrosamines.
    Hecht SS; Peterson LA; Spratt TE
    IARC Sci Publ; 1994; (125):91-106. PubMed ID: 7806343
    [No Abstract]   [Full Text] [Related]  

  • 33. Occurrence of and exposure to N-nitrosamines in Sweden: a review.
    Osterdahl BG
    IARC Sci Publ; 1991; (105):235-7. PubMed ID: 1855859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ specific genotoxicity and carcinogenicity.
    Pool BL; Schmezer P; Tompa A; Brendler SY
    Prog Clin Biol Res; 1990; 340D():33-41. PubMed ID: 2371304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-nitrosamines: environmental occurrence, in vivo formation and metabolism.
    Brunnemann KD; Hecht SS; Hoffmann D
    J Toxicol Clin Toxicol; 1982 Aug; 19(6-7):661-88. PubMed ID: 6761448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers.
    Foiles PG; Akerkar SA; Carmella SG; Kagan M; Stoner GD; Resau JH; Hecht SS
    Chem Res Toxicol; 1991; 4(3):364-8. PubMed ID: 1912321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tissue distribution and the tissue specificity of bioactivation of some tobacco-specific and some other N-nitrosamines.
    Tjälve H
    Crit Rev Toxicol; 1991; 21(4):265-94. PubMed ID: 2069712
    [No Abstract]   [Full Text] [Related]  

  • 38. Tobacco-specific nitrosamine-hemoglobin adducts.
    Hecht SS; Carmella SG; Murphy SE
    Methods Enzymol; 1994; 231():657-67. PubMed ID: 8041285
    [No Abstract]   [Full Text] [Related]  

  • 39. Tobacco nitrosamines as culprits in disease: mechanisms reviewed.
    Yalcin E; de la Monte S
    J Physiol Biochem; 2016 Mar; 72(1):107-20. PubMed ID: 26767836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational Prediction of Metabolic α-Carbon Hydroxylation Potential of
    Chakravarti S
    Chem Res Toxicol; 2023 Jun; 36(6):959-970. PubMed ID: 37267457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.